Biography
Dr. Raphael Bueno is the Chief of Thoracic Surgery at Brigham and Women's Hospital and the leader of the International Mesothelioma Program, succeeding the program's founder Dr. David Sugarbaker. Dr. Bueno is internationally recognized for his groundbreaking research in mesothelioma genomics — his team at Brigham published the first comprehensive genomic analysis of mesothelioma in Nature Genetics, identifying key mutations that drive the disease. He combines cutting-edge genomic research with surgical expertise, performing both EPP and P/D procedures. With over 350 publications, Dr. Bueno is one of the most published mesothelioma researchers in the world.
Education & Training
- Medical Degree — Harvard Medical School (Medicine)
- Residency — Massachusetts General Hospital (General Surgery)
- Fellowship — Brigham and Women's Hospital (Thoracic Surgery)
Specialties & Procedures
Clinical Specialties
- Thoracic Surgery
- Surgical Oncology
- Mesothelioma Genomics
Surgical Procedures
Board Certifications
- American Board of Thoracic Surgery
- American Board of Surgery
Research Focus
Mesothelioma genomics, precision medicine for thoracic malignancies, molecular subtypes of mesothelioma, and novel immunotherapy combinations.
Notable Publications
- Comprehensive genomic analysis of malignant pleural mesothelioma. Nature Genetics, 2018.
Treatment Center
Dr. Raphael Bueno practices at Brigham and Women's Hospital in Boston, MA.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
What is Dr. Bueno known for?
Dr. Bueno is known for leading the International Mesothelioma Program at Brigham and Women's Hospital and for his pioneering mesothelioma genomics research. His team published the first comprehensive genomic analysis of mesothelioma in Nature Genetics.
Did Dr. Bueno train with Dr. Sugarbaker?
Yes. Dr. Bueno trained at Brigham and Women's Hospital and now leads the International Mesothelioma Program founded by Dr. David Sugarbaker, building on that legacy with genomics-driven treatment approaches.